about
Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Osteoporosis piece of multi-morbidity puzzle in geriatric care.Maternal Active Mastication during Prenatal Stress Ameliorates Prenatal Stress-Induced Lower Bone Mass in Adult Mouse Offspring.Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?Colitis-induced bone loss is gender dependent and associated with increased inflammationAn N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excessMultidetector computed tomography-based microstructural analysis reveals reduced bone mineral content and trabecular bone changes in the lumbar spine after transarterial chemoembolization therapy for hepatocellular carcinoma.Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.Osteoimmunology and osteoporosis.The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritisFrequency of low bone mineral density in Saudi patients with inflammatory bowel diseaseCortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy.Obesity is not protective against fracture in postmenopausal women: GLOWShort-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study.Glucocorticoid-induced osteoporosis and parathyroid hormone.Thiazolidinediones and fracture risk in patients with Type 2 diabetes.Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.Management of glucocorticoid-induced osteoporosis.Advances in bone imaging for osteoporosis.The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis.Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor.Corticosteroid use in neuro-oncology: an update.Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.Renal association clinical practice guideline in post-operative care in the kidney transplant recipientGlucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis.Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis.Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone.Effect of β‑ecdysterone on glucocorticoid‑induced apoptosis and autophagy in osteoblasts.Adverse bone effects of medications used to treat non-skeletal disorders.Effects of eldecalcitol on bone and skeletal muscles in glucocorticoid-treated rats.Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids.Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.Bone Health in Adrenal Disorders.
P2860
Q30946308-C28B606F-3686-4641-AF6F-14938459D3B6Q33351754-40F0BDEB-3863-4077-AFD2-C995D8E7377BQ33702982-0F97CAC9-2548-4994-8A34-DC4A895868CCQ33912916-B72BCEA2-EB02-4084-A236-60A390F50D50Q34024554-1D872949-04D1-45A5-B7E4-5E74F2F41CEEQ34316496-CD8B997C-DD49-4CBF-98FA-2EE196DAAEC0Q34351974-A11382DB-8F8D-41FB-9237-BCB6EF67485EQ35463441-6B4DDDBA-AB99-46F1-8D18-AC1EACDF6C9FQ35840701-017942DD-5D72-469E-B18D-287066B5F804Q35934969-0227502B-B3C3-4379-A1AF-430E82A849E5Q36020939-40D9CD32-5EA4-43EE-BC2F-98DAD5F1FA78Q36903439-149B5064-90EC-46C0-8F91-2A18B3728837Q36980595-96E5821A-A232-4F21-B581-C76E6A7C3A63Q37067163-FF55FFA1-ED78-4540-BC6C-61D7F1BFA00CQ37534986-2B40FF7F-A16E-4B8B-8AA1-ADA8B613D891Q37720586-E322C79B-BDD3-4AF4-A162-AEE01E7E6CE5Q37799488-AAFEC240-0450-4AD8-96D3-904741FCF137Q37889370-E51680FC-00A6-4711-9B98-FCC53ADBCA6CQ37896546-97E5EDD9-1597-47B4-AA8D-FFD3919591BDQ37995500-84DD0C9B-81B7-4E01-B1A4-442DD1857FB5Q38033444-19E8A069-AB85-4F2E-8C96-680E1333E317Q38066699-0E6186BD-C1C4-46DB-9BBF-3ADE459601D6Q38184470-FD23FD79-CD74-4C75-96CB-1AA03B94F1F7Q38227083-86990234-D8C1-4966-9C07-3764FB5B6266Q38418725-18E0F2B4-75DE-41B6-BDC7-C99E34156308Q38512587-329B24F5-BA9F-471D-A239-B9C260A7F515Q39177137-AC4F77DF-9739-45B2-89E5-05D9251CB18CQ41523600-A32C10E6-4860-450F-BC3E-872F22471598Q42343473-53CCB584-703D-4EDA-A483-C82F7DF3AB50Q42576497-FBF08D98-2308-461A-894C-3FB10CAD499AQ43509107-9A433C9A-ACE7-4484-A89B-586330DD7D65Q44257423-EFB60FAD-0551-4F31-B1D4-245F2B488C6DQ44538830-C7D41B24-1A4D-4732-BD98-AC74F2AD5D74Q47427456-0FF477DE-2E80-4F89-82CE-4897AEEABC46Q48332195-EDEE9FE0-9F91-4F62-AEC7-8187A6229B7FQ51027441-5430976C-21F7-407C-9EA7-7A9427603776Q51296469-07C014F2-DAB6-4345-BC99-B72A5BF63C65Q51581540-BEE00F00-FE8F-4791-AFC0-7682FADEBF8FQ52845695-EC056C3E-9EA9-463B-86C7-F525B0A35E97Q55088148-C6AA90DC-0E33-495A-A1EE-A98707B38E9B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of glucocorticoid-induced osteoporosis.
@en
Management of glucocorticoid-induced osteoporosis.
@nl
type
label
Management of glucocorticoid-induced osteoporosis.
@en
Management of glucocorticoid-induced osteoporosis.
@nl
prefLabel
Management of glucocorticoid-induced osteoporosis.
@en
Management of glucocorticoid-induced osteoporosis.
@nl
P2860
P356
P1476
Management of glucocorticoid-induced osteoporosis.
@en
P2093
Juliet Compston
P2860
P2888
P356
10.1038/NRRHEUM.2009.259
P407
P577
2010-02-01T00:00:00Z